KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Change in Account Payables (2016 - 2026)

Esperion Therapeutics filings provide 8 years of Change in Account Payables readings, the most recent being -$12.4 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 233.76% to -$12.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 million, a 68.26% increase, with the full-year FY2025 number at $20.9 million, up 68.26% from a year prior.
  • Change in Account Payables hit -$12.4 million in Q4 2025 for Esperion Therapeutics, down from $2.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $27.8 million in Q1 2025 to a low of -$21.6 million in Q1 2021.
  • Median Change in Account Payables over the past 5 years was $2.1 million (2023), compared with a mean of $676600.0.
  • Biggest five-year swings in Change in Account Payables: crashed 2242.74% in 2022 and later surged 907.07% in 2025.
  • Esperion Therapeutics' Change in Account Payables stood at -$3.3 million in 2021, then soared by 236.99% to $4.5 million in 2022, then increased by 23.02% to $5.5 million in 2023, then skyrocketed by 69.04% to $9.3 million in 2024, then crashed by 233.76% to -$12.4 million in 2025.
  • The last three reported values for Change in Account Payables were -$12.4 million (Q4 2025), $2.9 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.